Balyasny Asset Management
KIN

Balyasny Asset Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Balyasny Asset Management’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-482,563
Closed -$4.42M – 2639
2021
Q2 		$4.42M Buy
+482,563
New +$2.81M 0.02% 755

Other funds holding KIN

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Balyasny Asset Management's KIN Position: Q3 2021 in Review

Balyasny Asset Management sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 482,563 shares — an estimated $4.42M sold.

Balyasny Asset Management first reported a position in KIN in Q2 2021 and held it in 1 quarter. The position peaked at $4.42M in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

  • Balyasny Asset Management reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Balyasny Asset Management sold 482,563 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $4.42M.
  • Balyasny Asset Management first reported a position in Kindred Biosciences, Inc. in Q2 2021 and held it in 1 quarter.
  • Balyasny Asset Management's Kindred Biosciences, Inc. position peaked at $4.42M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Balyasny Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.